Delivery Order SPE2DB20D2104-SPE2DB25FMCGB
Award Date
11/18/24
Potential Completion Date
11/19/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,308.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, and has an ultimate completion date of November 29, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,941.91 firm fixed-price delivery order contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has an ultimate completion date of April 2, 2025 and was awarded on April 1, 2025. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLIMEPIRIDE 4 MG TABLET 100S. The contract has a ceiling value of $2,051.72 and a performance period extending through March 8, 2024. This is a delivery order contract with a firm-fixed-price pricing structure. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
This federal contract award, valued at $5,186.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, with a completion date of October 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not set aside for any specific business category. Amerisourcebergen holds a...
This federal contract award, valued at $1,054.07, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a generic pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of June 4, 2024 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,153.02 Firm Fixed Price delivery order contract covers the supply of 4567721896 - GLIMEPIRIDE 4 MG TABLET 100S, with a performance period through March 28, 2025. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $4,292.98, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product, with a completion date of December 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA...
This federal contract award, valued at $1,530.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (SPE2DB22D1041|SPE2DB25FTYP7) for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLIMEPIRIDE 1 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,138.32 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRQV3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,616.85 firm fixed-price delivery order is for the supply of 4565256438 - GLIMEPIRIDE 4 MG TABLET 100S, a generic pharmaceutical product. The contract has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...